X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11880) 11880
Book Chapter (175) 175
Dissertation (25) 25
Magazine Article (22) 22
Publication (9) 9
Reference (6) 6
Web Resource (6) 6
Conference Proceeding (5) 5
Government Document (3) 3
Paper (2) 2
Book / eBook (1) 1
Book Review (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9766) 9766
imatinib mesylate (9256) 9256
science & technology (8641) 8641
life sciences & biomedicine (8319) 8319
benzamides (6874) 6874
pyrimidines - therapeutic use (4946) 4946
piperazines - therapeutic use (4760) 4760
male (4142) 4142
oncology (4028) 4028
antineoplastic agents - therapeutic use (3942) 3942
female (3739) 3739
imatinib (3670) 3670
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (3553) 3553
middle aged (3280) 3280
adult (2816) 2816
hematology (2753) 2753
pyrimidines - pharmacology (2464) 2464
aged (2398) 2398
piperazines - pharmacology (2347) 2347
chronic myeloid leukemia (2088) 2088
treatment outcome (1969) 1969
protein kinase inhibitors - therapeutic use (1798) 1798
animals (1773) 1773
antineoplastic agents - pharmacology (1468) 1468
pyrimidines - administration & dosage (1454) 1454
protein-tyrosine kinases - antagonists & inhibitors (1440) 1440
leukemia, myelogenous, chronic, bcr-abl positive - genetics (1433) 1433
piperazines - administration & dosage (1363) 1363
leukemia (1332) 1332
gastrointestinal stromal tumors - drug therapy (1329) 1329
cancer (1250) 1250
pyrimidines - adverse effects (1229) 1229
mutation (1187) 1187
hemic and lymphatic diseases (1147) 1147
piperazines - adverse effects (1143) 1143
drug resistance, neoplasm (1117) 1117
leukemia, myelogenous, chronic, bcr-abl positive - pathology (1108) 1108
fusion proteins, bcr-abl - genetics (1097) 1097
protein kinase inhibitors - pharmacology (1030) 1030
abridged index medicus (1018) 1018
mice (1017) 1017
antineoplastic agents (1005) 1005
antineoplastic agents - adverse effects (959) 959
care and treatment (950) 950
cell line, tumor (945) 945
antineoplastic agents - administration & dosage (900) 900
prognosis (893) 893
adolescent (881) 881
antimitotic agents (876) 876
aged, 80 and over (874) 874
tyrosine (874) 874
pharmacology & pharmacy (841) 841
imatinib mesylate - therapeutic use (824) 824
research (821) 821
dasatinib (801) 801
young adult (776) 776
benzamides - therapeutic use (772) 772
gastrointestinal stromal tumors - pathology (757) 757
medicine & public health (740) 740
apoptosis - drug effects (735) 735
analysis (729) 729
tumors (721) 721
neoplasms (713) 713
proto-oncogene proteins c-kit - genetics (692) 692
drug therapy (670) 670
fusion proteins, bcr-abl - metabolism (656) 656
kinases (650) 650
apoptosis (633) 633
cell biology (626) 626
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (601) 601
gastrointestinal stromal tumor (587) 587
hematology, oncology and palliative medicine (584) 584
drug resistance, neoplasm - genetics (577) 577
retrospective studies (570) 570
remission induction (568) 568
dose-response relationship, drug (566) 566
time factors (562) 562
fusion proteins, bcr-abl - antagonists & inhibitors (557) 557
biochemistry & molecular biology (554) 554
follow-up studies (550) 550
cell proliferation - drug effects (538) 538
cml (534) 534
genetic aspects (534) 534
k562 cells (534) 534
disease-free survival (527) 527
gastrointestinal stromal tumors - surgery (523) 523
surgery (516) 516
antineoplastic combined chemotherapy protocols - therapeutic use (507) 507
philadelphia chromosome (504) 504
health aspects (494) 494
gist (489) 489
imatinib mesylate - pharmacology (488) 488
signal transduction (483) 483
bcr-abl (481) 481
protein kinase inhibitors - administration & dosage (471) 471
gastrointestinal stromal tumors - genetics (458) 458
stem cells (455) 455
general & internal medicine (454) 454
gastrointestinal neoplasms - drug therapy (447) 447
protein kinase inhibitors - adverse effects (447) 447
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11253) 11253
Japanese (386) 386
Chinese (313) 313
French (161) 161
German (122) 122
Spanish (72) 72
Portuguese (44) 44
Korean (35) 35
Italian (33) 33
Russian (33) 33
Polish (22) 22
Hungarian (20) 20
Czech (14) 14
Danish (10) 10
Dutch (9) 9
Turkish (8) 8
Croatian (7) 7
Swedish (5) 5
Finnish (3) 3
Hebrew (3) 3
Romanian (3) 3
Ukrainian (3) 3
Bulgarian (2) 2
Indonesian (2) 2
Norwegian (2) 2
Slovak (2) 2
Lithuanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation (New York, N.Y.), ISSN 0009-7322, 03/2013, Volume 127, Issue 10, pp. 1128 - 1138
Journal Article
The Journal of immunology (1950), ISSN 1550-6606, 11/2008, Volume 181, Issue 10, pp. 6955 - 6963
Journal Article
Journal Article
Nature medicine, ISSN 1546-170X, 07/2006, Volume 12, Issue 8, pp. 908 - 916
Imatinib mesylate (Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl, the causal agent in chronic myelogenous leukemia... 
Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Mitochondria, Heart - ultrastructure | Piperazines - administration & dosage | Calcium - metabolism | Mitochondria, Heart - pathology | Sarcoplasmic Reticulum - drug effects | Humans | Piperazines - toxicity | Antineoplastic Agents - administration & dosage | Mitochondria, Heart - drug effects | Ventricular Dysfunction, Left - chemically induced | Antineoplastic Agents - toxicity | Dose-Response Relationship, Drug | Mitochondrial Membranes - drug effects | Pyrimidines - toxicity | Time Factors | Adenosine Triphosphatases - analysis | Antineoplastic Agents - adverse effects | Sarcoplasmic Reticulum - ultrastructure | Antineoplastic Agents - pharmacology | Cell Death - drug effects | Membrane Potentials - drug effects | Severity of Illness Index | Cytochromes c - secretion | Echocardiography | Pyrimidines - administration & dosage | Mice, Inbred C57BL | Cells, Cultured | Injections, Intraperitoneal | Adenosine Triphosphatases - metabolism | Heart Failure - pathology | Pyrimidines - pharmacology | Imatinib Mesylate | Piperazines - adverse effects | Piperazines - pharmacology | Ventricular Dysfunction, Left - physiopathology | Myocytes, Cardiac - pathology | Animals | Myocytes, Cardiac - drug effects | Cell Membrane Permeability - drug effects | Pyrimidines - adverse effects | Sarcoplasmic Reticulum - pathology | Mice | Benzamides | Myocytes, Cardiac - ultrastructure | Heart Failure - chemically induced | Heart failure | Chemotherapy | Side effects | Inhibitor drugs | Toxicity | Cardiovascular disease | Cancer | Index Medicus
Journal Article
Clinical cancer research, ISSN 1557-3265, 01/2008, Volume 14, Issue 2, pp. 352 - 359
Journal Article
Journal Article